{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:38:12Z","timestamp":1790746692776,"version":"4.1.0"},"reference-count":34,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Taipei Medical University, Wan Fang Hospital","award":["106-eva-03"],"award-info":[{"award-number":["106-eva-03"]}]},{"name":"Taipei Medical University, Wan Fang Hospital","award":["108-wf-eva-31"],"award-info":[{"award-number":["108-wf-eva-31"]}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["106TMU-WFH-11"],"award-info":[{"award-number":["106TMU-WFH-11"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["108TMU-WFH-25"],"award-info":[{"award-number":["108TMU-WFH-25"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,3,20]]},"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Numerous factors are associated with the risk of osteoporosis in patients with chronic kidney disease, including vitamin D deficiency, hypocalcaemia, hyperphosphataemia and secondary hyperparathyroidism. This study aimed to assess the correlation between cumulative erythropoietin (EPO) doses and osteoporosis risk in patients on chronic dialysis. A further objective was to determine the bone mineral density (BMD) of patients undergoing dialysis and its correlation with specific clinical and biochemical factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>The study was undertaken at a tertiary care centre within the southern region of the Taipei Metropolitan area.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>This cross-sectional study included 165 participants aged 41\u201390 years. Dual-energy X-ray absorptiometry was used to measure BMD. A total of 108 age-matched and sex-matched participants were selected for further analysis. Stepwise multiple regression analysis was used to investigate the relationship between bone measurements and bone diseases\u2019 risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcomes<\/jats:title>\n                    <jats:p>The primary outcome of this study was to assess the T-scores of the participants who received dialysis for more than 3\u2009months in our institution. The secondary outcome was using a receiver operating curve to predict osteoporosis development in patients on dialysis who received EPO treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean age of the participants was 66.6\u00b111.1 years. A total of 99 (60%) participants (41 men, 58\u2009women) were diagnosed as having osteoporosis. Fifty-four (32.7%) participants with T-scores &gt;\u22122.5 but &lt;\u22121.0 were diagnosed as having osteopenia. Osteoporotic participants received 1.61\u00b11.52\u2009million units EPO compared with nonosteoporotic participants, who received 1.01\u00b10.64\u2009million units (EPO1 model), p=0.015. The cumulative EPO dose negatively correlated with the T-scores of participants (p&lt;0.0001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>On the basis of the results of the study, cumulative EPO doses show a negative correlation with BMD development in patients on chronic dialysis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-056390","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T13:47:42Z","timestamp":1649771262000},"page":"e056390","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Single-centre cross-sectional study on the impact of cumulative erythropoietin on bone mineral density in maintenance dialysis patients"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1816-7215","authenticated-orcid":false,"given":"Chung-Yi","family":"Cheng","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"},{"name":"Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei Medical University, Taipei, Taiwan"},{"name":"Taipei Medical University Research Center of Urology and Kidney, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jie","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei Medical University, Taipei, Taiwan"},{"name":"Department of Orthopedic Surgery, Wan Fang Hospital, Taipei Medical University, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"2025121222584490000_12.4.e056390.1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1053\/ajkd.2002.32006","article-title":"Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures","volume":"39","author":"Jamal","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2025121222584490000_12.4.e056390.2","doi-asserted-by":"publisher","DOI":"10.1590\/S1807-59322011000600012"},{"key":"2025121222584490000_12.4.e056390.3","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1998.13.8.1213"},{"key":"2025121222584490000_12.4.e056390.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.00818.x"},{"key":"2025121222584490000_12.4.e056390.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0744"},{"key":"2025121222584490000_12.4.e056390.6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1242\/dev.129.2.505","article-title":"Erythropoietin receptor signalling is required for normal brain development","volume":"129","author":"Yu","year":"2002","journal-title":"Development"},{"key":"2025121222584490000_12.4.e056390.7","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M004999200"},{"key":"2025121222584490000_12.4.e056390.8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100665"},{"key":"2025121222584490000_12.4.e056390.9","doi-asserted-by":"publisher","DOI":"10.3109\/08977194.2011.637034"},{"key":"2025121222584490000_12.4.e056390.10","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-259085"},{"key":"2025121222584490000_12.4.e056390.11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051657"},{"key":"2025121222584490000_12.4.e056390.12","unstructured":"2019 official positions adult 1. Available: https:\/\/iscd.org\/wp-content\/uploads\/2021\/09\/2019-Official-Positions-Adult-1.pdf"},{"key":"2025121222584490000_12.4.e056390.13","unstructured":"Amgen . Aranesp, darbepoietin alpha. Available: https:\/\/www.aranesp.com\/professional\/nephrology\/dosing-options"},{"key":"2025121222584490000_12.4.e056390.14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4212\/cjhp.v65i6.1192","article-title":"Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to Canadian dialysis centres","volume":"65","author":"Jordan","year":"2012","journal-title":"Can J Hosp Pharm"},{"key":"2025121222584490000_12.4.e056390.15","doi-asserted-by":"crossref","first-page":"c81","DOI":"10.1159\/000183843","article-title":"Switching from epoetin alpha to darbepoetin alpha in Japanese hemodialysis patients: dose conversion ratio","volume":"111","author":"Hirai","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"2025121222584490000_12.4.e056390.16","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfp097"},{"key":"2025121222584490000_12.4.e056390.17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s42358-020-0118-0","article-title":"Mineral bone disorder and osteoporosis in hemodialysis patients","volume":"60","author":"Slouma","year":"2020","journal-title":"Adv Rheumatol"},{"key":"2025121222584490000_12.4.e056390.18","first-page":"149","article-title":"Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis","volume":"38","author":"Asaka","year":"1992","journal-title":"Clin Nephrol"},{"key":"2025121222584490000_12.4.e056390.19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000168600","article-title":"Bone mineral density in patients with end-stage renal failure","volume":"13","author":"Gabay","year":"1993","journal-title":"Am J Nephrol"},{"key":"2025121222584490000_12.4.e056390.20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/BF02556691","article-title":"Bone density of the radius, spine, and hip in relation to percent of ideal body weight in postmenopausal women","volume":"40","author":"Dawson-Hughes","year":"1987","journal-title":"Calcif Tissue Int"},{"key":"2025121222584490000_12.4.e056390.21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0272-6386(96)90461-8","article-title":"Prevalence and risk factors for osteopenia in dialysis patients","volume":"28","author":"Stein","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"2025121222584490000_12.4.e056390.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-005-1863-y"},{"key":"2025121222584490000_12.4.e056390.23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/8756-3282(95)80020-Q","article-title":"Reconstruction of cortical bone remodeling in untreated primary hyperparathyroidism and following surgery","volume":"16","author":"Brockstedt","year":"1995","journal-title":"Bone"},{"key":"2025121222584490000_12.4.e056390.24","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/11.7.1318"},{"key":"2025121222584490000_12.4.e056390.25","first-page":"28","article-title":"[Ultrasound bone measurement of the tibia: comparison with vertebral dual-energy X-ray absorptiometry and appendicular single photon absorptiometry]","volume":"20","author":"Xing","year":"1998","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"2025121222584490000_12.4.e056390.26","first-page":"2009","article-title":"Bone mineral density profile in uremic and renal transplant patients","volume":"26","author":"Chao","year":"1994","journal-title":"Transplant Proc"},{"key":"2025121222584490000_12.4.e056390.27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/8756-3282(94)90814-1","article-title":"Bone mineral densitometry in dialyzed patients: quantitative computed tomography versus dual photon absorptiometry","volume":"15","author":"Lechleitner","year":"1994","journal-title":"Bone"},{"key":"2025121222584490000_12.4.e056390.28","doi-asserted-by":"publisher","DOI":"10.1159\/000185620"},{"key":"2025121222584490000_12.4.e056390.29","first-page":"389","article-title":"The effect of oral 1 alpha-hydroxycalciferol treatment on bone mineral density in hemodialysis patients","volume":"46","author":"Morita","year":"1996","journal-title":"Clin Nephrol"},{"key":"2025121222584490000_12.4.e056390.30","first-page":"1155","article-title":"Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data","volume":"97","author":"Mikuls","year":"2005","journal-title":"J Natl Med Assoc"},{"key":"2025121222584490000_12.4.e056390.31","doi-asserted-by":"publisher","DOI":"10.1002\/art.21110"},{"key":"2025121222584490000_12.4.e056390.32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.xkme.2020.05.001","article-title":"Inflammation and erythropoiesis-stimulating agent hyporesponsiveness: a critical connection","volume":"2","author":"Shah","year":"2020","journal-title":"Kidney Med"},{"key":"2025121222584490000_12.4.e056390.33","article-title":"Platelets in inflammation: regulation of leukocyte activities and vascular repair","volume":"5","author":"Gros","year":"2014","journal-title":"Front Immunol"},{"key":"2025121222584490000_12.4.e056390.34","doi-asserted-by":"publisher","DOI":"10.1160\/TH14-12-1067"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-056390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:58:58Z","timestamp":1765609138000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-056390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,12]]},"published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1136\/bmjopen-2021-056390"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-056390","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}